Concepedia

Yoshikuni Nakamura

YN

Statistics

Publications

24

Citations

907

H-Index

19

Active since

1987

Affiliations

Senju Pharmaceutical (Japan)(Current)

Oregon Health & Science University

Yamaguchi University

Kyushu University

Senju Pharmaceutical (United States)

Yoshikuni Nakamura is an author at Senju Pharmaceutical (Japan) specializing in medicine, ophthalmology, and calpain-mediated proteolysis.

Publications per year

1987–2011

24

Publications

24

SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses

Chiho Fukiage, Mitsuyoshi Azuma, Yoshikuni Nakamura et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 1997 · 74 citations

Medicine, Medicinal Chemistry, Ophthalmology +8

Signaling mechanism of TGF-beta1-induced collagen contraction mediated by bovine trabecular meshwork cells.

Yoshikuni Nakamura, Shinji Hirano, Katsuyoshi SUZUKI et al. · PubMed · 2002 · 71 citations

Life Sciences, Cell Biology, Cell Signaling +16

Evidence for Apoptosis in the Selenite Rat Model of Cataract

Yoshiyuki Tamada, Chiho Fukiage, Yoshikuni Nakamura et al. · Biochemical and Biophysical Research Communications · 2000 · 67 citations

Medicine, Cell Biology, Ophthalmology +12

Active matrix metalloproteinases in the tear fluid of individuals with vernal keratoconjunctivitis

Naoki Kumagai, Kazutaka Yamamoto, Ken Fukuda et al. · Journal of Allergy and Clinical Immunology · 2002 · 65 citations · Full text

Medicine, Ophthalmology, Pathology +13

Contribution of calpain Lp82-induced proteolysis to experimental cataractogenesis in mice.

Yoshikuni Nakamura, Chiho Fukiage, Meng-Fu Maxwell Shih et al. · PubMed · 2000 · 63 citations

Medicine, Biochemistry, Ophthalmology +14

1–5 of 24